VP, Biometrics at Bicycle Therapeutics

Lexington, Massachusetts, United States -

Full Time

Start Date

Immediate

Expiry Date

22 Sep, 26

Salary

325000.0

Posted On

24 Jun, 26

Experience

10 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

Skills

Biostatistics, Clinical Study Design, Oncology Drug Development, Regulatory Advocacy, Adaptive Designs, Bayesian Approaches, CDISC Standards, SAS, R, CRO Management, Clinical Programming, Statistical Analysis Plans, Radiopharmaceutical Methodology, Team Leadership, Data Integrity, Global Regulatory Compliance

Industry

Biotechnology Research

Description

Company Description Bicycle Therapeutics is a clinical-stage pharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycle® molecules attractive candidates for drug development. The company is evaluating nuzafatide pevedotin (formerly BT5528), a Bicycle® Drug Conjugate (BDC®) targeting EphA2, a historically undruggable target; a pipeline of Bicycle® Radioconjugates (BRCs) and imaging agents;; zelenectide pevedotin (formerly BT8009), a BDC® targeting Nectin-4, a well-validated tumor antigen; and, through various partnerships, the use of Bicycle® technology to develop therapies to treat diseases in a range of therapeutic areas. Bicycle Therapeutics is a clinical-stage pharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycle molecules attractive candidates for drug development. The company is evaluating nuzafatide pevedotin (formerly 5528), a Bicycle® Drug Conjugate (BDC®) targeting EphA2, a historically undruggable target, in company-sponsored clinical trials, a pipeline of other bicycle-based conjugate molecules, including Bicycle® Radioconjugates (BRC®) for radiopharmaceutical use; and zelenectide pevedotin (formerly BT8009), a BDC targeting Nectin-4, a well-validated tumor antigen, in company-sponsored clinical trials. Bicycle Therapeutics is headquartered in Cambridge, UK, with many key functions and members of its leadership team located in Lexington, Massachusetts, USA. For more information, visit bicycletherapeutics.com Culture is key and all Bicycle employees actively embrace and role model our company values: We are Adventurous. We believe it’s the way to deliver extraordinary results for our patients. We are Dedicated to our Mission. You can’t change the world if you don’t have determination. We are One Team. We only succeed when we work together. Job Description The Vice President, Biometrics will build, resource, and oversee the Biometrics organization. This leader holds ultimate accountability for clinical study designs, statistical methodologies, data analysis, and interpretation of results in close collaboration with partner functions across Clinical Development, Operations, and Regulatory Affairs. As a key member of the Development Leadership Team, the VP provides strategic statistical input into Bicycle's drug development portfolio, representing the company in interactions with global Health Authorities (FDA, EMA, MHRA) and contributing to the advancement of our oncology and radiopharmaceutical clinical pipelines. Additionally, this role supports early-stage research and translational sciences as required. The ideal candidate possesses deep global clinical development expertise in oncology, combined with an outstanding track record of managing complex portfolios, driving innovation in applied statistical methodologies (including adaptive designs), and leading teams in a high-growth, agile biotechnology environment. KEY RESPONSIBILITIES Operational Leadership: Ensure highly effective and compliant global operations in biostatistics and clinical/statistical programming, establishing industry-best standard operating procedures (SOPs). Strategic Input: Lead Biometrics participation in clinical development plans (CDPs), clinical protocols, investigator brochures, regulatory briefing documents, and scientific publications. Statistical Integrity: Drive the development, implementation, and execution of robust statistical analysis plans (SAPs) that support clinical protocols, ensuring absolute data integrity, accuracy, and regulatory compliance. Radiopharmaceutical and BRC Support: Provide specialized statistical guidance for the expanding Bicycle® Radioconjugate (BRC®) portfolio, incorporating imaging endpoints, dosimetry analysis, and theranostic study designs. CRO & Vendor Management: Oversee the strategic selection and management of CRO partners, holding accountability for the quality, consistency, and timeliness of external programming deliverables (such as SDTM/ADaM datasets and TFLs). Regulatory Advocacy: Represent Bicycle as the lead statistical expert in interactions with global regulatory bodies (FDA, EMA, MHRA), aligning statistical strategies with current guidelines (including Project Optimus). Team Building & Mentorship: Recruits, retains, and mentors a high-performing biostatistics and programming team, fostering a culture of scientific excellence, accountability, and continuous professional development. External Engagement: Cultivate strong collaborative relationships with external investigators, steering committees, and academic thought leaders, actively contributing to the broader biostatistics community. Qualifications Background: Proven experience leading a biometrics function, with a PhD qualification or a Masters with equivalent industry experience Clinical Expertise: Proven track record in oncology drug development (Phase I through Phase III). Experience or strong familiarity with radiopharmaceutical/imaging clinical trial methodology is highly desirable. Regulatory Acumen: Comprehensive, up-to-date knowledge of ICH, FDA, EMA, and global regulatory guidance documents, with direct experience presenting statistical strategies to regulatory agencies. Statistical Methodologies: Deep expertise in advanced theoretical and applied statistics, including adaptive designs, Bayesian approaches, and master protocols. Technical Proficiency: Expert-level understanding of statistical software (SAS, R, etc.) and industry data standards (CDISC). Leadership & Influence: Highly collaborative leader with exceptional interpersonal, communication, and negotiation skills; a proven ability to lead by example and thrive in a fast-paced, cross-functional environment Urgency & Quality: An entrepreneurial self-starter who balances a strong sense of urgency and rapid clinical execution with rigorous scientific standards and ethical integrity. Additional Information State-of-the-art campus environment with on campus restaurant and Montessori nursery Flexible working environment Competitive reward including annual company bonus Employee recognition schemes 28 days annual leave in addition to bank holidays + option to buy up to 5 additional days annually Employer contribution to pension (employee does not have to contribute) Life assurance cover 4x basic salary Private Medical Insurance, including optical and dental cover Enhanced parental leave policies Group income protection Employee assistance program Health Cash Plan Access to company subsidized gym membership Eligibility for an option grant to subscribe to shares in Bicycle Therapeutics plc. Cycle to work scheme Bicycle Therapeutics is committed to building a diverse workforce that is representative of the communities we serve. We recognize that diverse and inclusive teams build a stronger and more innovative company. Therefore, all qualified applicants will be considered for employment, and we do not discriminate on the basis of race, religion, colour, gender, sexual orientation, age, disability status, marital status, or veteran status. Department: Development Compensation: USD 260000 - USD 325000 - yearly

Responsibilities

The VP of Biometrics will build and oversee the biometrics organization, holding ultimate accountability for clinical study designs and statistical methodologies. This leader will provide strategic input for the drug development portfolio and represent the company before global health authorities.